Basic Information

Gene symbol S Synonyms E2 Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas
Description spike glycoprotein

GTO ID GTC2810
Trial ID NCT05077254
Disease COVID-19
Altered gene S
Therapeutic/Target gene Therapeutic gene
TherapymRNA vaccine
Co-treatment SOC IS Regimen
PhasePhase2
Recruitment statusRecruiting
TitleA Randomized Study to Evaluate Antibody Response to an Additional Dose of SARS-CoV-2 Vaccination With and Without Immunosuppression Reduction in Kidney and Liver Transplant Recipients
Year2021
CountryUnited States
Company sponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Other ID(s)DAIT COVID19-TB-03|U01AI138897|NIAID CRMS ID#: 38892
Vector information
Vectorlipid nanoparticle

Clinical Result

Cohort1: Pfizer-BioNTech COVID-19 Vaccine_SOC IS Regimen
Administration route intramuscular injection
Dosage Pfizer-BioNTech COVID-19 Vaccine, one dose
Age Adult, Older_Adult
References PMID: 35933295
Cohort2: Pfizer-BioNTech COVID-19 Vaccine_SOC IS Reduction
Administration route intramuscular injection
Dosage Pfizer-BioNTech COVID-19 Vaccine, one dose
Age Adult, Older_Adult
References PMID: 35933295
Cohort3: Moderna COVID-19 Vaccine_SOC IS Regimen
Administration route intramuscular injection
Dosage Moderna COVID-19 Vaccine, one dose
Age Adult, Older_Adult
References PMID: 35933295
Cohort4: Moderna COVID-19 Vaccine_SOC IS Reduction
Administration route intramuscular injection
Dosage Moderna COVID-19 Vaccine, one dose
Age Adult, Older_Adult
References PMID: 35933295

Relationship Graph

Overview of Knowledge Graph